Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma: Risk factors and clinical consequences

Cancer

Volumn 106, Issue 2, 2006, Pages 329-336

  Vera Llonch, Montserrat ^a   Oster, Gerry ^a   Hagiwara, May ^a   Sonis, Stephen ^b  

^a POLICY ANALYSIS INC PAI   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Carcinoma; Oral mucositis; Outcomes; Radiation therapy; Risk

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LIP CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; REVIEW; RISK FACTOR; TUMOR LOCALIZATION;

AGED; CARCINOMA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RADIATION INJURIES; RISK FACTORS; STOMATITIS;

EID: 30744450928     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21622     Document Type: Review

References (27)

1. Rose-Ped AM, Bellm LA, Epstein JB, et al. Complications of radiation therapy for head and neck cancer. The patient's perspective. Cancer Nurs. 2002;25:461-467.
2. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253-262.
3. Ruescher TJ, Sodeifi A, Scrivani SJ, et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer. 1998;82:2275-2281.
4. Sonis S, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem cell transplantation. J Clin Oncol. 2001;19:2201-2205.
5. Bensadoun RJ, Magne N, Marcy PY, et al. Chemotherapy-and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment. Eur Arch Otorhinolaryngol. 2001;258:481-487.
6. Barasch A, Peterson DE. Risk factors for ulcerative mucositis in cancer patients: unanswered questions. Oral Oncol 2003;39:91-100.
7. Shih A, Miaskowski C, Dodd MJ, Stotts NA, MacPhail L. Mechanisms for radiation-induced oral mucositis and the consequences. Cancer Nurs. 2003;26:222-229.
8. Marcial VA, Pajak T, Kramer S, et al. Radiation Therapy Oncology Group (RTOG) studies in head and neck cancer. Semin Oncol. 1988;15:39-60.
9. Sonis ST. Oral complications of cancer therapy. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 4th edition. Philadelphia: J.B. Lippincott, 1993:2385.
10. Sonis ST. Epidemiology, frequency, distribution, mechanisms and histopathology. In: Peterson DE, Sonis ST, editors. Oral complications of cancer chemotherapy. The Hague: Martinius Nijhoff, 1983:1-12.
11. Sanchiz F, Milla A, Tomer J. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 1990;19:1347-1350.
12. Browman GP, Cripps C, Hodson DI, et al. Placebo controlled randomized trial of infusion fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol. 1994;12:2648-2653.
13. Fu KK, Philips TL, Silverberg IJ, et al. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer. J Clin Oncol. 1987;5:1410-1418.
14. Weissberg JB, Son YH, Papac RJ, et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys. 1989;17:3-9.
15. Bachaud JM, David JM, Boussin G, Daly N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys. 1991;20:243-246.
16. Merlano M, Corvo R, Margarino G, et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck: the final report of a randomized trial. Cancer. 1991;67:915-921.
17. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med. 1992;327:1115-1121.
18. Salvajoli JV, Morioka H, Trippe N, Kowalski LP. A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 1992;249:211-215.
19. Haffty BG, Son YH, Sasaki CT, et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys. 1993;27:241-250.
20. Smid L, Lesnicar H, Zakotnik B, et al. Radiotherapy combined with simultaneous chemotherapy with mitomycin, and bleomycin for inoperable head and neck cancer-preliminary report. Int J Radiat Oncol Biol Phys. 1995;32:769-775.
21. Taylor SG, Murthy AK, Vannetzel JM, et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J Clin Oncol. 1994;12:385-395.
22. Johnson CR, Schmidt-Ullrich RK, Wazer DE. Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck. Cancer. 1992;69:2749-2754.
23. Pinto LHJ, Canary PCV, Araujo CMM, Bacelar SC, Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1991;21:557-562.
24. Horiot JC, LeFur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol. 1992;25:231-241.
25. Fu KK, Pakaj TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
26. nd edition. Cary, NC: SAS Institute Inc., 2000.
27. Epstein JB, Schubert MM. Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology. 2003;17:1767-1779.